γ-Hydroxybutyrate (GHB) induces GABAB receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on GHB or GABAB receptors of medium spiny neurons in the nucleus accumbens

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We report on cellular actions of the illicit recreational drug γ-hydroxybutyrate (GHB) in the brain reward area nucleus accumbens. First, we compared the effects of GHB and the GABAB receptor agonist baclofen. Neither of them affected the membrane currents of medium spiny neurons in rat nucleus accumbens slices. GABAergic and glutamatergic synaptic potentials of medium spiny neurons, however, were reduced by baclofen but not GHB. These results indicate the lack of GHB as well as postsynaptic GABAB receptors, and the presence of GHB insensitive presynaptic GABAB receptors in medium spiny neurons. In astrocytes GHB induced intracellular Ca2+ transients, preserved in slices from GABAB receptor type 1 subunit knockout mice. The effects of tetrodotoxin, zero added Ca2+ with/without intracellular Ca2+ store depletor cyclopiazonic acid or vacuolar H-ATPase inhibitor bafilomycin A1 indicate that GHB-evoked Ca2+ transients depend on external Ca2+ and intracellular Ca2+ stores, but not on vesicular transmitter release. GHB-induced astrocytic Ca2+ transients were not affected by the GHB receptor-specific antagonist NCS-382, suggesting the presence of a novel NCS-382-insensitive target for GHB in astrocytes. The activation of astrocytes by GHB implies their involvement in physiological actions of GHB. Our findings disclose a novel profile of GHB action in the nucleus accumbens. Here, unlike in other brain areas, GHB does not act on GABAB receptors, but activates an NCS-382 insensitive GHB-specific target in a subpopulation of astrocytes. The lack of either post- or presynaptic effects on medium spiny neurons in the nucleus accumbens distinguishes GHB from many drugs and natural rewards with addictive properties and might explain why GHB has only a weak reinforcing capacity.

Original languageEnglish
Pages (from-to)268-281
Number of pages14
JournalNeuroscience
Volume162
Issue number2
DOIs
Publication statusPublished - Aug 18 2009

Fingerprint

Hydroxybutyrates
Nucleus Accumbens
Astrocytes
Neurons
Street Drugs
Reward
GABA-B Receptors
Vacuolar Proton-Translocating ATPases
Presynaptic Receptors
Synaptic Potentials
Baclofen
Tetrodotoxin
Brain
Knockout Mice
Membranes
Pharmaceutical Preparations
NCS 382

Keywords

  • abuse
  • GABA receptor knockout mice
  • intracellular Ca store
  • NCS-382
  • reward area

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{dabeeead674f4a8f9e066e11b507f94b,
title = "γ-Hydroxybutyrate (GHB) induces GABAB receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on GHB or GABAB receptors of medium spiny neurons in the nucleus accumbens",
abstract = "We report on cellular actions of the illicit recreational drug γ-hydroxybutyrate (GHB) in the brain reward area nucleus accumbens. First, we compared the effects of GHB and the GABAB receptor agonist baclofen. Neither of them affected the membrane currents of medium spiny neurons in rat nucleus accumbens slices. GABAergic and glutamatergic synaptic potentials of medium spiny neurons, however, were reduced by baclofen but not GHB. These results indicate the lack of GHB as well as postsynaptic GABAB receptors, and the presence of GHB insensitive presynaptic GABAB receptors in medium spiny neurons. In astrocytes GHB induced intracellular Ca2+ transients, preserved in slices from GABAB receptor type 1 subunit knockout mice. The effects of tetrodotoxin, zero added Ca2+ with/without intracellular Ca2+ store depletor cyclopiazonic acid or vacuolar H-ATPase inhibitor bafilomycin A1 indicate that GHB-evoked Ca2+ transients depend on external Ca2+ and intracellular Ca2+ stores, but not on vesicular transmitter release. GHB-induced astrocytic Ca2+ transients were not affected by the GHB receptor-specific antagonist NCS-382, suggesting the presence of a novel NCS-382-insensitive target for GHB in astrocytes. The activation of astrocytes by GHB implies their involvement in physiological actions of GHB. Our findings disclose a novel profile of GHB action in the nucleus accumbens. Here, unlike in other brain areas, GHB does not act on GABAB receptors, but activates an NCS-382 insensitive GHB-specific target in a subpopulation of astrocytes. The lack of either post- or presynaptic effects on medium spiny neurons in the nucleus accumbens distinguishes GHB from many drugs and natural rewards with addictive properties and might explain why GHB has only a weak reinforcing capacity.",
keywords = "abuse, GABA receptor knockout mice, intracellular Ca store, NCS-382, reward area",
author = "T. Moln{\'a}r and K. Antal and G. Nyitrai and Z. Emri",
year = "2009",
month = "8",
day = "18",
doi = "10.1016/j.neuroscience.2009.05.017",
language = "English",
volume = "162",
pages = "268--281",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - γ-Hydroxybutyrate (GHB) induces GABAB receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on GHB or GABAB receptors of medium spiny neurons in the nucleus accumbens

AU - Molnár, T.

AU - Antal, K.

AU - Nyitrai, G.

AU - Emri, Z.

PY - 2009/8/18

Y1 - 2009/8/18

N2 - We report on cellular actions of the illicit recreational drug γ-hydroxybutyrate (GHB) in the brain reward area nucleus accumbens. First, we compared the effects of GHB and the GABAB receptor agonist baclofen. Neither of them affected the membrane currents of medium spiny neurons in rat nucleus accumbens slices. GABAergic and glutamatergic synaptic potentials of medium spiny neurons, however, were reduced by baclofen but not GHB. These results indicate the lack of GHB as well as postsynaptic GABAB receptors, and the presence of GHB insensitive presynaptic GABAB receptors in medium spiny neurons. In astrocytes GHB induced intracellular Ca2+ transients, preserved in slices from GABAB receptor type 1 subunit knockout mice. The effects of tetrodotoxin, zero added Ca2+ with/without intracellular Ca2+ store depletor cyclopiazonic acid or vacuolar H-ATPase inhibitor bafilomycin A1 indicate that GHB-evoked Ca2+ transients depend on external Ca2+ and intracellular Ca2+ stores, but not on vesicular transmitter release. GHB-induced astrocytic Ca2+ transients were not affected by the GHB receptor-specific antagonist NCS-382, suggesting the presence of a novel NCS-382-insensitive target for GHB in astrocytes. The activation of astrocytes by GHB implies their involvement in physiological actions of GHB. Our findings disclose a novel profile of GHB action in the nucleus accumbens. Here, unlike in other brain areas, GHB does not act on GABAB receptors, but activates an NCS-382 insensitive GHB-specific target in a subpopulation of astrocytes. The lack of either post- or presynaptic effects on medium spiny neurons in the nucleus accumbens distinguishes GHB from many drugs and natural rewards with addictive properties and might explain why GHB has only a weak reinforcing capacity.

AB - We report on cellular actions of the illicit recreational drug γ-hydroxybutyrate (GHB) in the brain reward area nucleus accumbens. First, we compared the effects of GHB and the GABAB receptor agonist baclofen. Neither of them affected the membrane currents of medium spiny neurons in rat nucleus accumbens slices. GABAergic and glutamatergic synaptic potentials of medium spiny neurons, however, were reduced by baclofen but not GHB. These results indicate the lack of GHB as well as postsynaptic GABAB receptors, and the presence of GHB insensitive presynaptic GABAB receptors in medium spiny neurons. In astrocytes GHB induced intracellular Ca2+ transients, preserved in slices from GABAB receptor type 1 subunit knockout mice. The effects of tetrodotoxin, zero added Ca2+ with/without intracellular Ca2+ store depletor cyclopiazonic acid or vacuolar H-ATPase inhibitor bafilomycin A1 indicate that GHB-evoked Ca2+ transients depend on external Ca2+ and intracellular Ca2+ stores, but not on vesicular transmitter release. GHB-induced astrocytic Ca2+ transients were not affected by the GHB receptor-specific antagonist NCS-382, suggesting the presence of a novel NCS-382-insensitive target for GHB in astrocytes. The activation of astrocytes by GHB implies their involvement in physiological actions of GHB. Our findings disclose a novel profile of GHB action in the nucleus accumbens. Here, unlike in other brain areas, GHB does not act on GABAB receptors, but activates an NCS-382 insensitive GHB-specific target in a subpopulation of astrocytes. The lack of either post- or presynaptic effects on medium spiny neurons in the nucleus accumbens distinguishes GHB from many drugs and natural rewards with addictive properties and might explain why GHB has only a weak reinforcing capacity.

KW - abuse

KW - GABA receptor knockout mice

KW - intracellular Ca store

KW - NCS-382

KW - reward area

UR - http://www.scopus.com/inward/record.url?scp=67649341982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649341982&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2009.05.017

DO - 10.1016/j.neuroscience.2009.05.017

M3 - Article

VL - 162

SP - 268

EP - 281

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 2

ER -